Minor cannabinoids to be studied as part of NIH epilepsy programme
A Canadian cannabis company is set to study minor cannabinoids for the treatment of epilepsy as part of a National Institute of Health (NIH) programme. Cannabis research company, Cannabis Orchards, has signed an agreement with the National Institute of Health (NIH) to participate in the Epilepsy [...]